Thema
prev ...
Clinical Trial, Phase III
6
Diseases
6
HIV Protease Inhibitors
6
JE6H2O27P8
6
Lentivirus
6
Letter
6
Medical conditions
6
Microbiology
6
Microorganisms
6
Oncogenic viruses
6
Primate lentiviruses
6
Pyrimidinones
6
Retroviridae
6
Risk factors
6
Viral Load
6
efavirenz
6
Alkynes
5
Antibiotics, Antitubercular
5
Antiinfectives
5
Antiretrovirals
5
Antivirals
5
Benzoxazines
5
Cyclopropanes
5
Isoniazid
5
Medical sciences
5
Medications
5
Pharmaceutical preparations
5
Pharmaceutics
5
Resource-limited setting
5
SARS-CoV-2
5
V83O1VOZ8L
5
Acids
4
Ad26COVS1
4
Antibodies, Viral
4
COVID-19 Vaccines
4
Chemical compounds
4
Chemicals
4
Chemistry
4
Clinical Trial, Phase II
4
DNA, Bacterial
4
Human Immunodeficiency Virus
4
Immune system diseases
4
Immunoglobulin G
4
JT2NS6183B
4
Major Articles and Brief Reports
4
Moxifloxacin
4
Nucleic acids
4
Physical sciences
4
RNA
4
Resource-limited settings
4
mehr ...